SLXN
NASDAQ · Biotechnology
Silexion Therapeutics Corp
$0.25
-0.01 (-4.57%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+14,489.4% upside
Low Target
$26.81
Average Target
$36.24
High Target
$52.45
Current Price
$0.25
Current
$0.25
$0.25
Target
$36.24
$36.24
$26.81
$36.24 avg
$52.45
Scenario Analysis
Bear Case
$26.81
10,693.1%
Low target
Base Case
$36.24
+14,489.4%
Avg target
Bull Case
$52.45
+21,015.1%
High target
Risk/Reward
2.0x
Balanced
Price in Context
Target vs 52W High
$36.24
-14.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |